Effects of blood pressure lowering with perindopril and indapamide therapy on dementia and cognitive decline in patients with cerebrovascular disease.

By C. Tzourio, C. Anderson, N. Chapman, M. Woodward, B. Neal, S. MacMahon, J. Chalmers. Archives of Internal Medicine, 2003

972 citations recorded by the source corpus.

Subfields: Epidemiology, Psychiatry and Mental health, Pulmonary and Respiratory Medicine

View Paper: https://www.semanticscholar.org/paper/2f4ed51228da2afc1fd3e42d5d8f3c7fdedd2686

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Epidemiology

1. Rhian M. Touyz

In Psychiatry and Mental health

1. David H. Salat

In Pulmonary and Respiratory Medicine

1. H. Rosas
2. David H. Salat
3. J. Jean Chen

Citations in the corpus

• Epidemiology of Alzheimer Disease (2012, neutral): “Hypertension is a treatable medical disorder, but clinical trials of antihypertensive medications in AD patients have been attempted with inconsistent results (Forette et al. 2002; Lithell et al. 2003; Tzourio et al. 2003; Peters et al. 2010).”
• 2024 ESC Guidelines for the management of elevated blood pressure and hypertension. (2024, positive): “469 While individual trials have had mixed results, meta-analysis of these RCTs, including SPRINT MIND, reported a reduced risk of incident dementia or cognitive impairment with BP lowering of 7%–13%.”